216 related articles for article (PubMed ID: 18563304)
1. Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the 'cerebral diabetes paradigm'.
Brewer JK
J Mol Neurosci; 2008 Jul; 35(3):307-22. PubMed ID: 18563304
[TBL] [Abstract][Full Text] [Related]
2. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
3. Role of proto-oncogene activation in carcinogenesis.
Anderson MW; Reynolds SH; You M; Maronpot RM
Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
[TBL] [Abstract][Full Text] [Related]
4. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms.
Juhasz G; Chase D; Pegg E; Downey D; Toth ZG; Stones K; Platt H; Mekli K; Payton A; Elliott R; Anderson IM; Deakin JF
Neuropsychopharmacology; 2009 Jul; 34(8):2019-27. PubMed ID: 19242408
[TBL] [Abstract][Full Text] [Related]
5. A genetic rat model of depression, Flinders sensitive line, has a lower density of 5-HT(1A) receptors, but a higher density of 5-HT(1B) receptors, compared to control rats.
Nishi K; Kanemaru K; Diksic M
Neurochem Int; 2009; 54(5-6):299-307. PubMed ID: 19121358
[TBL] [Abstract][Full Text] [Related]
6. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
7. Differential oncogenic Ras signaling and senescence in tumor cells.
Bihani T; Mason DX; Jackson TJ; Chen SC; Boettner B; Lin AW
Cell Cycle; 2004 Sep; 3(9):1201-7. PubMed ID: 15492501
[TBL] [Abstract][Full Text] [Related]
8. The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans.
Ribeiro L; Busnello JV; Cantor RM; Whelan F; Whittaker P; Deloukas P; Wong ML; Licinio J
Neuroreport; 2007 Aug; 18(12):1291-3. PubMed ID: 17632285
[TBL] [Abstract][Full Text] [Related]
9. c-Ha-ras gene mutation and activation precede pathological changes in DMBA-induced in vivo carcinogenesis.
Kwong YY; Husain Z; Biswas DK
Oncogene; 1992 Aug; 7(8):1481-9. PubMed ID: 1630811
[TBL] [Abstract][Full Text] [Related]
10. N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation.
Kannan P; Buettner R; Chiao PJ; Yim SO; Sarkiss M; Tainsky MA
Genes Dev; 1994 Jun; 8(11):1258-69. PubMed ID: 7926729
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications.
Imperial R; Toor OM; Hussain A; Subramanian J; Masood A
Semin Cancer Biol; 2019 Feb; 54():14-28. PubMed ID: 29175106
[TBL] [Abstract][Full Text] [Related]
12. The role of non-ras transforming genes in chemical carcinogenesis.
Cooper CS
Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
[TBL] [Abstract][Full Text] [Related]
13. RAS mutations in human cancers: Roles in precision medicine.
Murugan AK; Grieco M; Tsuchida N
Semin Cancer Biol; 2019 Dec; 59():23-35. PubMed ID: 31255772
[TBL] [Abstract][Full Text] [Related]
14. Genetic link between cancer and thrombosis.
Boccaccio C; Comoglio PM
J Clin Oncol; 2009 Oct; 27(29):4827-33. PubMed ID: 19738115
[TBL] [Abstract][Full Text] [Related]
15. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
Barnoud T; Schmidt ML; Donninger H; Clark GJ
Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
[TBL] [Abstract][Full Text] [Related]
16. Laboratory probing of oncogenes from human liquid and solid specimens as markers of exposure to toxicants.
Nelson E
Crit Rev Toxicol; 1996 Sep; 26(5):483-549. PubMed ID: 8891429
[TBL] [Abstract][Full Text] [Related]
17. Effect of Ha-rasval12 on nm23 expression, tumor formation and metastasis of the transformants, and immunomodulation in tumor-bearing mice.
Hsieh CC; Wu SY; Lan SH; Weng TY; Tsai Y; Liu HS
Anticancer Res; 2010 Sep; 30(9):3585-92. PubMed ID: 20944141
[TBL] [Abstract][Full Text] [Related]
18. The activated human c-Ha-ras-1 oncogene as a mutagen.
Baron HM; Bobrisheva IV; Varshaver NB
Cancer Genet Cytogenet; 1992 Aug; 62(1):15-20. PubMed ID: 1521228
[TBL] [Abstract][Full Text] [Related]
19. The ras gene family and human carcinogenesis.
Bos JL
Mutat Res; 1988 May; 195(3):255-71. PubMed ID: 3283542
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
